Recombinetics logo — Delivering the Next Evolution of Healthcare

Recombinetics

Delivering the Next Evolution of Healthcare

Founded 2008 United States Eagan, United States 17 employees Series A Total: $65.86M Biotechnology, Health Care +1

General Information

Company Name Recombinetics
Founded Year 2008
Location United States Eagan, United States +1
Founders / Decision Makers
Team member
Employees 17
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series A
Social

Get notified when Recombinetics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Recombinetics

Recombinetics, founded in 2008, is a global leader in proprietary gene repair and gene-editing technology. The company's breakthrough scientific research and development of TALEN and CRISPR (Cas9) gene editing technologies has resulted in breakthroughs in regenerative medicine, disease research, and animal agriculture. Led by a team of expert geneticists, genome engineers, and reproductive physiologists, the company is headquartered in St. Paul, Minnesota. Recombinetics operates in the biotechnology, healthcare, and life sciences industries. The company recently secured a Series A investment on 21 August 2018. The details of the investors involved in this funding round were not disclosed. Recombinetics' focus on gene editing technologies places it at the forefront of the evolving healthcare landscape, with potential applications across various sectors including medicine, research, and agriculture.

Taxonomy: gene editing, regenerative medicine, disease research, animal agriculture, biomedical research, livestock productivity, precision breeding, pre-clinical research, genetic engineering, genome editing, aquaculture, geneticists, genome engineers, reproductive physiologists, biomedicine

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• - 21 Aug 2018
Venture Round •••••• - 08 Mar 2018
Funding Round •••••• - 11 Jan 2018
Venture Round •••••• - 02 Oct 2017
Debt Financing •••••• - 27 Apr 2017

View All 11 Funding Rounds

Recombinetics Alternatives & Competitors

Recombinetics vs

Dedicated to Improving Life.

Post Ipo Equity
98 employees
Biotechnology, Health Care
Recombinetics vs

Accelerating Genome Engineering

Series Unknown
11 employees
Biotechnology
Recombinetics vs

Edit the Code of Life, Creating Transformative Solutions for Serious Diseases.

Series B
46 employees
Biotechnology, Health Care
Also compare with: Recombinetics vs ToolGen Inc. ToolGen Inc.

FAQ About Recombinetics

Delivering the Next Evolution of Healthcare
Recombinetics was founded in 2008.
Recombinetics is headquartered in Eagan, United States.
Recombinetics operates in the following industries: Biotechnology, Health Care, Life Sciences.
Recombinetics has approximately 17 employees.
Recombinetics has completed 11 funding rounds, raising a total of $65.86M. The latest funding stage is Series A.
Top alternatives and competitors to Recombinetics include Precision BioSciences, Inc., Countagen, EdiGene Inc., ToolGen Inc., EmendoBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Recombinetics and Precision BioSciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Recombinetics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy